|
1
|
Leon-Ferre RA and Goetz MP: Advances in
systemic therapies for triple negative breast cancer. BMJ.
381:e0716742023. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Teichgraeber DC, Guirguis MS and Whitman
GJ: Breast cancer staging: Updates in the AJCC cancer staging
manual, 8th edition, and current challenges for radiologists, from
the AJR special series on cancer staging. AJR Am J Roentgenol.
217:278–290. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen X, Chen A, Liu C and Zhang B:
Triple-negative breast cancer with dermatomyositis: A case report
and literature review. Cancer Manag Res. 14:569–576. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aebi S, Karlsson P and Wapnir IL: Locally
advanced breast cancer. Breast. 62 (Suppl 1):S58–S62. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
O'Connell KA and LaChance AH:
Dermatomyositis. N Engl J Med. 384:24372021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang S, Anderson HJ and Lee JB:
Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan
syndrome: Part II. Diagnosis and management. J Am Acad Dermatol.
91:13–22. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sardiña González C, Martínez Vivero C and
López Castro J: Paraneoplastic syndromes review: The great
forgotten ones. Crit Rev Oncol Hematol. 174:1036762022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang SH, Chang C and Lian ZX: Polymyositis
and dermatomyositis-challenges in diagnosis and management. J
Transl Autoimmun. 2:1000182019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Inaguma G, Shimada A, Tsunoda J, Matsuzaki
T, Nishi T, Seki H and Matsumoto H: Inflammatory breast cancer
associated with amyopathic dermatomyositis: A case report. Surg
Case Rep. 6:2842020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Piras M, Panebianco M, Garibaldi M,
Roberto M, Merlonghi G, Pellegrini P and Marchetti P: A Case of
pathological complete response and resolution of dermatomyositis
following neoadjuvant chemotherapy in HER2-positive early breast
cancer. Curr Oncol. 28:1957–1961. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dias LPN, Faria ALA, Scandiuzzi MM, Inhaia
CLCS, Shida JY and Gebrim LH: A rare case of severe myositis as
paraneoplastic syndrome on breast cancer. World J Surg Oncol.
13:1342015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Werner JM, Wlodarczyk J and Seruya M:
Diagnostic accuracy of manual muscle testing to identify nerve
transfer candidates in children with acute flaccid myelitis. Plast
Reconstr Surg. 152:1057–1067. 2023.PubMed/NCBI
|
|
13
|
Spak DA, Plaxco JS, Santiago L, Dryden MJ
and Dogan BE: BI-RADS® fifth edition: A summary of
changes. Diagn Interv Imaging. 98:179–190. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ren X, Song Y, Zhang Y, Wu H, Chen L, Pang
J, Zhou L, Shen S and Liang Z: Prognostic significance of different
molecular typing methods and immune status based on RNA sequencing
in HR-positive and HER2-negative early-stage breast cancer. BMC
Cancer. 22:5482022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Khanna U, Galimberti F, Li Y and Fernandez
AP: Dermatomyositis and malignancy: Should all patients with
dermatomyositis undergo malignancy screening? Ann Transl Med.
9:4322021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Daryanani S: Dermatomyositis and breast
cancer. J Clin Oncol. 16:2890–2891. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Azar L and Khasnis A: Paraneoplastic
rheumatologic syndromes. Curr Opin Rheumatol. 25:44–49. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang Q, Lyu K, Li J, Zhang P, Guan W,
Zhang L, Han L, Liu S and Li T: Anti-melanoma
differentiation-associated 5 gene antibody-positive dermatomyositis
exhibit three clinical phenotypes with different prognoses. Clin
Exp Rheumatol. 40:304–308. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nombel A, Fabien N and Coutant F:
Dermatomyositis with anti-MDA5 antibodies: Bioclinical features,
pathogenesis and emerging therapies. Front Immunol. 12:7733522021.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Blaes F: Pathogenesis, diagnosis and
treatment of paraneoplastic neurologic syndromes. Expert Rev
Neurother. 21:675–686. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen KL, Zeidi M and Werth VP: Recent
advances in pharmacological treatments of adult dermatomyositis.
Curr Rheumatol Rep. 21:532019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nagaraju K and Lundberg IE: Polymyositis
and dermatomyositis: Pathophysiology. Rheum Dis Clin North Am.
37159–171. (v)2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Akagi H and Wada T: A case in which breast
cancer developed at the same time as dermatomyositis, and the onset
of new cancer was able to be predicted by the exacerbating skin
symptoms and parallel increase in the anti-TIF1-γ antibody levels.
Intern Med. 62:3057–3062. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cobos GA, Femia A and Vleugels RA:
Dermatomyositis: An update on diagnosis and treatment. Am J Clin
Dermatol. 21:339–353. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gordon PA, Winer JB, Hoogendijk JE and
Choy EH: Immunosuppressant and immunomodulatory treatment for
dermatomyositis and polymyositis. Cochrane Database Syst Rev.
2012:CD0036432012.PubMed/NCBI
|
|
26
|
Gradishar WJ, Moran MS, Abraham J,
Abramson V, Aft R, Agnese D, Allison KH, Anderson B, Burstein HJ,
Chew H, et al: NCCN guidelines® insights: Breast cancer,
version 4.2023. J Natl Compr Canc Netw. 21:594–608. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Leatham H, Schadt C, Chisolm S, Fretwell
D, Chung L, Callen JP and Fiorentino D: Evidence supports blind
screening for internal malignancy in dermatomyositis: Data from 2
large US dermatology cohorts. Medicine (Baltimore). 97:e96392018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tryfonidis K, Senkus E, Cardoso MJ and
Cardoso F: Management of locally advanced breast
cancer-perspectives and future directions. Nat Rev Clin Oncol.
12:147–162. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gu J, Tong T, Xu D, Cheng F, Fang C, He C,
Wang J, Wang B, Yang X, Wang K, et al: Deep learning radiomics of
ultrasonography for comprehensively predicting tumor and axillary
lymph node status after neoadjuvant chemotherapy in breast cancer
patients: A multicenter study. Cancer. 129:356–366. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Maire M, Debled M, Petit A, Fournier M,
Macgrogan G, Quenel-Thueux N, Charitansky H, Mathoulin-Pelissier S,
Bonnefoi H and Tunon de Lara C: Neoadjuvant chemotherapy and
radiotherapy for locally advanced breast cancer: Safety and
efficacy of reverse sequence compared to standard technique? Eur J
Surg Oncol. 48:1699–1705. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sousa C, Cruz M, Neto A, Pereira K,
Peixoto M, Bastos J, Henriques M, Roda D, Marques R, Miranda C, et
al: Neoadjuvant radiotherapy in the approach of locally advanced
breast cancer. ESMO Open. 4 (Suppl 2):e0006402020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Primiano G, Plantone D, Sauchelli D,
Cuccagna C, Renna R, Iorio R and Servidei S: Resolution of muscle
inflammation after tumor removal in a woman with paraneoplastic
dermatomyositis. J Rheumatol. 39:2359–2360. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Racanelli V, Prete M, Minoia C, Favoino E
and Perosa F: Rheumatic disorders as paraneoplastic syndromes.
Autoimmun Rev. 7:352–358. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bogdanov I, Kazandjieva J, Darlenski R and
Tsankov N: Dermatomyositis: Current concepts. Clin Dermatol.
36:450–458. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fiorentino DF and Casciola-Rosen L:
Autoantibodies and cancer association: The case of systemic
sclerosis and dermatomyositis. Clin Rev Allergy Immunol.
63:330–341. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Firmat F and Lipsett MB: Cancer and
dermatomyositis. Cancer. 11:63–66. 1958. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ogawa M, Sugiura K, Yokota K, Muro Y and
Akiyama M: Anti-transcription intermediary factor 1-γ
antibody-positive clinically amyopathic dermatomyositis complicated
by interstitial lung disease and breast cancer. J Eur Acad Dermatol
Venereol. 30:373–375. 2016. View Article : Google Scholar : PubMed/NCBI
|
